Institutional Ownership Vera Therapeutics, Inc. (VERA)
This table provides information about the institutional ownership of Vera Therapeutics, Inc. (VERA). We have compiled data on the 184 institutions that hold shares in the stock, with a total of 55.1 Million shares, which have been reported (via 13F filing form) to have a value of $2.53 Billion.
| Holding | Report Date | shares Held | Holding Value (Reported) | Last Trade | Trade History |
|---|---|---|---|---|---|
|
Avoro Capital Advisors LLC
New York, NY |
Nov 14, 2024 Q3 2024 |
4,309,590
shares
|
$198 Million
2.87% of portfolio
|
Q2 2024
Reduced 18.15%
|
|
|
Price T Rowe Associates Inc
Baltimore, MD |
Nov 14, 2024 Q3 2024 |
3,939,109
shares
|
$181 Million
0.02% of portfolio
|
Q3 2024
Added 8.81%
|
|
|
Black Rock Inc.
New York, NY |
Aug 13, 2024 Q2 2024 |
3,337,672
shares
|
$153 Million
0.0% of portfolio
|
Q2 2024
Added 0.56%
|
|
|
Abingworth LLP
London, X0 |
Feb 10, 2023 Q4 2022 |
2,960,231
shares
|
$136 Million
19.0% of portfolio
|
Q2 2021
New holding
|
|
|
Sofinnova Investments, Inc.
Menlo Park, CA |
Nov 13, 2024 Q3 2024 |
2,793,987
shares
|
$128 Million
11.68% of portfolio
|
Q4 2023
Added 24.09%
|
|
|
Vanguard Group Inc
Valley Forge, PA |
Nov 13, 2024 Q3 2024 |
2,580,177
shares
|
$118 Million
0.0% of portfolio
|
Q3 2024
Added 2.22%
|
|
|
Commodore Capital LP
New York, NY |
Nov 14, 2024 Q3 2024 |
2,475,000
shares
|
$114 Million
9.29% of portfolio
|
Q2 2024
Reduced 21.8%
|
|
|
Eversept Partners, LP
New York, NY |
Nov 14, 2024 Q3 2024 |
2,050,157
shares
|
$94.1 Million
7.17% of portfolio
|
Q3 2024
Added 0.34%
|
|
|
Holocene Advisors, LP
New York, NY |
Nov 14, 2024 Q3 2024 |
1,954,528
shares
|
$89.7 Million
0.38% of portfolio
|
Q3 2024
Added 8.82%
|
|
|
State Street Corp
Boston, MA |
Nov 14, 2024 Q3 2024 |
1,823,807
shares
|
$83.7 Million
0.0% of portfolio
|
Q3 2024
Reduced 15.39%
|
|
|
Kynam Capital Management, LP
Princeton, NJ |
Nov 14, 2024 Q3 2024 |
1,576,549
shares
|
$72.4 Million
5.72% of portfolio
|
Q3 2024
Added 2.13%
|
|
|
Adage Capital Partners Gp, L.L.C.
Boston, MA |
Nov 14, 2024 Q3 2024 |
1,374,000
shares
|
$63.1 Million
0.11% of portfolio
|
Q3 2024
Added 22.79%
|
|
|
Samlyn Capital, LLC
New York, NY |
Nov 14, 2024 Q3 2024 |
1,359,227
shares
|
$62.4 Million
0.97% of portfolio
|
Q3 2024
Added 10.33%
|
|
|
Paradigm Biocapital Advisors LP
New York, NY |
Nov 14, 2024 Q3 2024 |
1,096,851
shares
|
$50.3 Million
1.75% of portfolio
|
Q3 2024
New holding
|
|
|
Geode Capital Management, LLC
Boston, MA |
Nov 12, 2024 Q3 2024 |
1,004,665
shares
|
$46.1 Million
0.0% of portfolio
|
Q3 2024
Added 2.05%
|
|
|
Woodline Partners LP
San Francisco, CA |
Nov 14, 2024 Q3 2024 |
1,000,893
shares
|
$45.9 Million
0.4% of portfolio
|
Q3 2024
Added 5.48%
|
|
|
T. Rowe Price Investment Management, Inc.
Baltimore, MD |
Nov 14, 2024 Q3 2024 |
984,001
shares
|
$45.2 Million
0.03% of portfolio
|
Q3 2024
New holding
|
|
|
Pictet Asset Management Sa
Geneva 73, V8 |
Aug 10, 2023 Q2 2023 |
919,352
shares
|
$42.2 Million
0.02% of portfolio
|
Q2 2023
New holding
|
|
|
Siren, L.L.C.
New York, NY |
Nov 13, 2024 Q3 2024 |
837,928
shares
|
$38.5 Million
1.85% of portfolio
|
Q3 2024
New holding
|
|
|
Deutsche Bank Ag\
Frankfurt Am Main, 2M |
Nov 13, 2024 Q3 2024 |
766,544
shares
|
$35.2 Million
0.01% of portfolio
|
Q3 2024
Added 20.65%
|
|
|
International Biotechnology Trust PLC
London, X0 |
Nov 14, 2023 Q3 2023 |
758,355
shares
|
$34.8 Million
3.53% of portfolio
|
Q3 2023
Reduced 22.24%
|
|
|
First Light Asset Management, LLC
Edina, MN |
Nov 14, 2024 Q3 2024 |
705,234
shares
|
$32.4 Million
2.71% of portfolio
|
Q3 2024
Reduced 29.88%
|
|
|
Altium Capital Management LP
New York, NY |
Nov 14, 2024 Q3 2024 |
684,000
shares
|
$31.4 Million
10.66% of portfolio
|
Q3 2024
Reduced 4.2%
|
|
|
Orbimed Advisors LLC
San Diego, CA |
Nov 14, 2024 Q3 2024 |
675,872
shares
|
$31 Million
0.7% of portfolio
|
Q1 2024
Reduced 55.48%
|
|
|
Goldman Sachs Group Inc
New York, NY |
Nov 14, 2024 Q3 2024 |
599,854
shares
|
$27.5 Million
0.0% of portfolio
|
Q3 2024
Reduced 23.54%
|